Kiniksa Pharmaceuticals Ltd (KNSA)
19.76
-0.35
(-1.74%)
USD |
NASDAQ |
May 17, 16:00
19.76
0.00 (0.00%)
After-Hours: 20:00
Kiniksa Pharmaceuticals Total Assets (Quarterly): 519.67M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 519.67M |
| December 31, 2023 | 526.32M |
| September 30, 2023 | 483.06M |
| June 30, 2023 | 484.33M |
| March 31, 2023 | 442.86M |
| December 31, 2022 | 459.67M |
| September 30, 2022 | 459.95M |
| June 30, 2022 | 210.58M |
| March 31, 2022 | 230.96M |
| December 31, 2021 | 232.80M |
| September 30, 2021 | 252.86M |
| June 30, 2021 | 279.21M |
| March 31, 2021 | 311.16M |
| Date | Value |
|---|---|
| December 31, 2020 | 349.46M |
| September 30, 2020 | 384.41M |
| June 30, 2020 | 271.44M |
| March 31, 2020 | 226.11M |
| December 31, 2019 | 254.53M |
| September 30, 2019 | 281.80M |
| June 30, 2019 | 308.14M |
| March 31, 2019 | 346.16M |
| December 31, 2018 | 321.96M |
| September 30, 2018 | 347.10M |
| June 30, 2018 | 365.13M |
| March 31, 2018 | 224.78M |
| December 31, 2017 | 47.49M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
210.58M
Minimum
Jun 2022
526.32M
Maximum
Dec 2023
348.47M
Average
309.65M
Median
Total Assets (Quarterly) Benchmarks
| Amicus Therapeutics Inc | 721.79M |
| Geron Corp | 482.07M |
| United Therapeutics Corp | 6.495B |
| Vanda Pharmaceuticals Inc | 652.68M |
| TG Therapeutics Inc | 373.32M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 87.78M |
| Shareholders Equity (Quarterly) | 431.90M |
| Current Ratio | 4.214 |